Associate Professor, Anaesthesia, Brigham and Women's Hospital, Harvard Medical School

Anesthesiology

Dr. Simon C. Body, MD

Simon C. Body, MD works in the field of Anesthesiology. Doctor Simon C. Body, MD is also published. He has 42 publications published. The lastest publication: "Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.' He is registered with Medicare and accepts Medicare payments.

Publications

Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study.
Using Next-generation RNA Sequencing to Examine Ischemic Changes Induced by Cold Blood Cardioplegia on the Human Left Ventricular Myocardium Transcriptome.
Bicuspid Aortic Valve: Identifying Knowledge Gaps and Rising to the Challenge From the International Bicuspid Aortic Valve Consortium (BAVCon).
Surgical treatment of bicuspid aortic valve disease: knowledge gaps and research perspectives.
Increased Perioperative B-type Natriuretic Peptide Associates with Heart Failure Hospitalization or Heart Failure Death after Coronary Artery Bypass Graft Surgery.
Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury.
Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1.
Assessment of preoperative B-type natriuretic peptide in adult surgeries: is it useful?
Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery.
Genome-wide assessment for genetic variants associated with ventricular dysfunction after primary coronary artery bypass graft surgery.
From creatine kinase-MB to troponin: do we really need to differentiate between myocardial injury and infarction?
Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery.
Postoperative activity, but not preoperative activity, of antithrombin is associated with major adverse cardiac events after coronary artery bypass graft surgery.
Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements.
Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations.
Effect of the perioperative blood transfusion and blood conservation in cardiac surgery clinical practice guidelines of the Society of Thoracic Surgeons and the Societ...
The effect of the perioperative blood transfusion and blood conservation in cardiac surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the So...
Comparison of the utility of preoperative versus postoperative B-type natriuretic peptide for predicting hospital length of stay and mortality after primary coronary a...
Common genetic variants on chromosome 9p21 predict perioperative myocardial injury after coronary artery bypass graft surgery.
Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells.
Antiplatelet agents used for early intervention in acute coronary syndrome: myocardial salvage versus bleeding complications.
Variation in the 4q25 chromosomal locus predicts atrial fibrillation after coronary artery bypass graft surgery.
Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting.
Genomics: Implications for anesthesia, perioperative care and outcomes.
Impact of genetic variation on perioperative bleeding.
Genomics: risk and outcomes in cardiac surgery.
Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.
Full disclosure: not just of conflict, but also of data.
Limitations of genetic findings that are not in Hardy-Weinberg equilibrium.
The MBL2 'LYQA secretor' haplotype is an independent predictor of postoperative myocardial infarction in whites undergoing coronary artery bypass graft surgery.
Pro: Aprotinin has a good efficacy and safety profile relative to other alternatives for prevention of bleeding in cardiac surgery.
Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes.
Influence of statins on perioperative outcomes.
Genetic influences on cardiac surgical outcomes.
Pharmacogenetics of anesthetic and analgesic agents.
Competing risks: preoperative myocardial infarction or postoperative bleeding?
Predictive genomics of adverse events after cardiac surgery.
Utility of intraoperative transesophageal echocardiography for diagnosis of pulmonary embolism.
Endocarditis of a left ventricular assist device resulting in regurgitant flow.
Use of a modified single-lumen endobronchial tube in severe tracheobronchial compression.
Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.

Doctors Specialties

Anesthesiology

Accepted Insurances

Fallon Community Health Plan
First Health (Coventry Health Care) PPO
Medicare MCR
Tufts Health Plans
Tufts PPO

Hospital

Brigham and Women's Hospital

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1285685792
Last Name Of The Provider	BODY
First Name Of The Provider	SIMON
View All

Similar Doctors

	Dr. Peter F. Dunn, MD This Doctor is OpenDoctor Recommended.
	Dr. Thomas M. Burch, MD This Doctor is OpenDoctor Recommended.
	Dr. Christina A. Jelly, MD This Doctor is OpenDoctor Recommended.
	Dr. Andres T. Navedo-Rivera, MD
	Dr. Pete L. Pelletier, MD
	Dr. John C. Markley, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard M. Loomis, MD

Associate Professor, Anaesthesia, Brigham and Women&#39;s Hospital, Harvard Medical School